Comparative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines among Veterans: 2015–2016 and 2016–2017 Seasons
نویسندگان
چکیده
1464. Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016 Fiona P. Havers, MD, MHS; Kate Russell, MD, MPH; Jessie Chung, MPH; Arnold S. Monto, MD, FIDSA; Emily T. Martin, MPH, PhD; Edward A. Belongia, MD; Huong Q. McLean, PhD, MPH; Manjusha Gaglani, MBBS; Kempapura Murthy, MBBS, MPH; Richard K. Zimmerman, MD MPH, FIDSA; Mary Patricia Nowalk, PhD; Michael L. Jackson, PhD, MPH; Lisa A. Jackson, MD, MPH, FIDSA and Brendan L. Flannery, PhD; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, Marshfield Clinic Research Institute, Marshfield, Wisconsin, Marshfield Clinic R esearch Foundation, Marshfield, Wisconsin, Pediatrics; Pediatric Infectious Diseases, Baylor Scott & White Health; Texas A&M University HSC COM, Temple, Texas, Baylor Scott & White Health, Temple, Texas, University of Pittsburgh, Pittsburgh, Pennsylvania, Kaiser Permanente Washington Health Research Institute, Seattle, Washington
منابع مشابه
Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.
BACKGROUND Influenza is a significant cause of morbidity and mortality in older adults. High-dose (HD) trivalent inactivated vaccine has increased immunogenicity in older adults compared with standard-dose (SD) vaccine. We assessed the relative effectiveness of HD influenza vaccination (vs SD influenza vaccination). METHODS We conducted a retrospective cohort study among patients who receive ...
متن کاملComparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
BACKGROUND A high-dose trivalent inactivated influenza vaccine was licensed in 2009 by the US Food and Drug Administration (FDA) on the basis of serological criteria. We sought to establish whether high-dose inactivated influenza vaccine was more effective for prevention of influenza-related visits and hospital admissions in US Medicare beneficiaries than was standard-dose inactivated influenza...
متن کاملInfluenza Vaccine Effectiveness in the United States During the 2016–2017 Season
BACKGROUND The A(H1N1)pdm09 virus strain used in the live attenuated influenza vaccine was changed for the 2015-2016 influenza season because of its lack of effectiveness in young children in 2013-2014. The Influenza Vaccine Effectiveness Network evaluated the effect of this change as part of its estimates of influenza vaccine effectiveness in 2015-2016. METHODS We enrolled patients 6 months ...
متن کاملRecommendations for Prevention and Control of Influenza in Children, 2016-2017.
The purpose of this statement is to update recommendations for the routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The AAP recommends annual seasonal influenza immunization for everyone 6 months and older, including children and adolescents. Highlights for the upcoming 2016-2017 season include the following: 1. Annua...
متن کاملEarly 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0-14, 15-64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65-79 and ≥...
متن کامل